Sanchez Ramiro
Insider CIK 1830326 · CERE Chief Medical Officer · ANRO Director · RAPP Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RAPP Rapport Therapeutics, Inc. | P Buy | 2026-10-23 | 2026-10-23 | 3,600 | $27.35 | $98.5K | 3,600 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | A Award deriv | 2026-06-10 | 2026-06-10 | 15,200 | — | $0 | 15,200 | SEC↗ |
| ANRO Alto Neuroscience, Inc. | A Award deriv | 2026-05-12 | 2026-05-14 | 10,958 | — | $0 | 10,958 | SEC↗ |
| ANRO Alto Neuroscience, Inc. | A Award deriv | 2026-01-02 | 2026-01-06 | 3,806 | $11.82 | $45.0K | 3,806 | SEC↗ |
| ANRO Alto Neuroscience, Inc. | A Award deriv | 2025-08-12 | 2025-08-14 | 30,574 | — | $0 | 30,574 | SEC↗ |
| ANRO Alto Neuroscience, Inc. | A Award deriv | 2025-08-12 | 2025-08-14 | 3,928 | $2.21 | $8.7K | 3,928 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | A Award deriv | 2025-06-17 | 2025-06-18 | 10,925 | — | $0 | 10,925 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | A Award deriv | 2024-11-07 | 2024-11-07 | 29,756 | — | $0 | 29,756 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | D To issuer deriv | 2024-08-01 | 2024-08-05 | 87,573 | — | $0 | 0 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | D To issuer deriv | 2024-08-01 | 2024-08-05 | 1,393,153 | — | $0 | 0 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | D To issuer | 2024-08-01 | 2024-08-05 | 14,673 | — | $0 | 0 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | A Award deriv | 2024-01-19 | 2024-01-23 | 87,573 | — | $0 | 87,573 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise deriv | 2023-12-26 | 2023-12-28 | 10,000 | — | $0 | 538,435 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | S Sale | 2023-12-26 | 2023-12-28 | 10,000 | $42.47 | $424.7K | 14,673 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise | 2023-12-26 | 2023-12-28 | 10,000 | $3.50 | $35.0K | 24,673 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | S Sale | 2023-12-20 | 2023-12-21 | 10,152 | $41.42 | $420.5K | 14,673 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise deriv | 2023-12-19 | 2023-12-21 | 24,825 | — | $0 | 0 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise | 2023-12-19 | 2023-12-21 | 24,825 | — | $0 | 24,825 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise deriv | 2023-12-15 | 2023-12-19 | 7,500 | — | $0 | 123,390 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | S Sale | 2023-12-15 | 2023-12-19 | 7,500 | $41.39 | $310.4K | 0 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise | 2023-12-15 | 2023-12-19 | 7,500 | $9.88 | $74.1K | 7,500 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise deriv | 2023-12-07 | 2023-12-11 | 10,000 | — | $0 | 548,435 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise | 2023-12-07 | 2023-12-11 | 10,000 | $3.50 | $35.0K | 10,000 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | S Sale | 2023-12-07 | 2023-12-11 | 10,000 | $41.37 | $413.7K | 0 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | A Award deriv | 2023-02-06 | 2023-02-08 | 24,825 | — | $0 | 24,825 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | A Award deriv | 2023-02-06 | 2023-02-08 | 97,691 | — | $0 | 97,691 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | A Award deriv | 2022-02-09 | 2022-02-11 | 168,856 | — | $0 | 168,856 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | A Award deriv | 2021-02-03 | 2021-02-05 | 278,637 | — | $0 | 278,637 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | A Award deriv | 2020-10-28 | 2020-10-30 | 130,890 | — | $0 | 130,890 | SEC↗ |